Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Todos Medical's share price for the quarter that ended in Sep. 2022 was $0.0178. Todos Medical's Shares Outstanding (EOP) for the quarter that ended in Sep. 2022 was 1,354.37 Mil. Therefore, Todos Medical's market cap for the quarter that ended in Sep. 2022 was $24.11 Mil.
Todos Medical's quarterly market cap
increased
from Mar. 2022 ($0.00 Mil) to Jun. 2022 ($15.99 Mil) and
increased
from Jun. 2022 ($15.99 Mil) to Sep. 2022 ($24.11 Mil).
Todos Medical's annual market cap
increased
from Dec. 2019 ($4.14 Mil) to Dec. 2020 ($28.23 Mil) and
increased
from Dec. 2020 ($28.23 Mil) to Dec. 2021 ($57.03 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Todos Medical's Enterprise Value for Today is $0.00 Mil.
Todos Medical (OTCPK:TOMDF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Todos Medical Market Cap Related Terms
Todos Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Todos Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Todos Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Todos Medical Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Todos Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Todos Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Todos Medical's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Todos Medical (TOMDF) has a Market Cap of $0.00 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Todos Medical and its competitors.
Is Todos Medical's Market Cap too high?
Todos Medical's current Market Cap is $0.00 Mil.
How does Todos Medical's Market Cap compare to NDRA and IDXG?
Todos Medical's Market Cap of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. The industry median Market Cap is 57.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 57.30, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Todos Medical and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 57.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Todos Medical's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Todos Medical stock overvalued right now?
Todos Medical (TOMDF) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Todos Medical (TOMDF), the current Market Cap is $0.00 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TOMDF has been successfully added to your 